If you need more lookups,
subscriptions start at $34 USD/month.
Gary Waanders Location
Switzerland
Gary Waanders Work
Head of Investor Relations and Communications @ (November 2021 - Present)
Vice President Investor Relations @ (August 2019 - June 2021)
Managing Director - UK Healthcare Research @ Bryan, Garnier & Co. (September 2017 - July 2019)
Director, Healthcare Research @ (January 2014 - June 2017)
Director, Equity Research @ (June 2005 - September 2013)
Biotech Analyst @ (January 2001 - March 2005)
Project Leader - Cancer Vaccines and Drug Delivery Systems @ (March 1997 - August 1999)
Post-doctoral Fellow @ (October 1990 - January 1997)
Gary Waanders Education
Durham University
MBA (Business Administration)
1999-2000
Monash University
BSC (Hons), PhD (Immunology)
1981-1990
Gary Waanders Skills
Biotechnology
IPO
Investment Banking
Valuation
Financial Modeling
Due Diligence
Mergers
Equities
Financial Analysis
Investments
Private Equity
Hedge Funds
Cancer
Business Development
Business Strategy
Restructuring
Corporate Development
Mergers & Acquisitions
Equity Research
Venture Capital
Emerging Markets
Capital Markets
Equity Capital Markets
Equity Valuation
Investment Management
Life Sciences
Strategy
Pharmaceutical Industry
Investor Relations
Finance
Healthcare
Strategic Planning
Molecular Biology
Change Management
Project Management
Mergers and Acquisitions
Cell Culture
Leadership
Research
Gary Waanders Summary
Gary Waanders, based in Switzerland, is currently a Head of Investor Relations and Communications at AC Immune. Gary Waanders brings experience from previous roles at Medigene AG, Bryan, Garnier & Co., Zeus Capital and Nomura Code Securities. Gary Waanders holds a 1999 - 2000 MBA in Business Administration @ Durham University. With a robust skill set that includes Biotechnology, IPO, Investment Banking, Valuation, Financial Modeling and more. Gary Waanders has 2 emails and 1 mobile phone numbers on RocketReach.
Looking for a different Gary Waanders?
Find contact details for 700 million professionals.